Evidence for a genetic association between monoamine oxidase A and restless legs syndrome

Neurology

Volumn 59, Issue 2, 2002, Pages 215-219

  Desautels, A ^a,b   Turecki, G ^b   Montplaisir, J ^a   Brisebois, K ^c   Sequeira, A ^b   Adam, B ^a   Rouleau, G A ^b,c  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; DINUCLEOTIDE;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; HUMAN; IMMOBILIZATION; INTRON; LATENT PERIOD; MALE; ONSET AGE; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SLEEP; TANDEM REPEAT;

EID: 0037162352     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.2.215     Document Type: Article

References (35)

1. A questionnaire study of 138 patients with restless legs syndrome: The 'Night-Walkers' survey
2. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria
3. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients
4. Restless legs syndrome in monozygotic twins: Clinical correlates
5. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q
6. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review
7. Treatment of restless legs syndrome with levodopa plus benserazide
8. Restless legs syndrome and periodic leg movements in sleep: The primary role of dopaminergic mechanism
9. Dopamine D2 receptor alteration in patients with periodic movements in sleep (Nocturnal myoclonus)
10. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies
11. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome
12. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep
13. Human monoamine oxidase A gene determines levels of enzyme activity
14. Some puzzling pharmacological effects of monoamine oxidase inhibitors
15. cDNA cloning of human liver monoamine oxidase A and B: Molecular basis of differences in enzymatic properties
16. The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions
17. Human monoamine oxidase A and B genes exhibit identical exon-intron organization
18. Dopaminergic neurotransmission and restless legs syndrome: A genetic association analysis
19. Toward a better definition of the restless legs syndrome
20. Periodic leg movements in sleep (nocturnal myoclonus) and restless legs syndrome
21. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome
22. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder
23. Highly polymorphic (GT)n repeat sequence in intron II of the human MAOB gene
24. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci
25. Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAOA promoter-associated variable number tandem repeat
26. Prevalence and risk factors of RLS in an elderly population: The MEMO study. Memory and morbidity in Augsburg Elderly
27. Ovarian hormones influence the morphology, distribution, and density of tyrosine hydroxylase immunoreactive axons in the dorsolateral prefrontal cortex of adult rhesus monkeys
28. Sex differences and effects of estrogen on dopamine and DOPAC release from the striatum of male and female CD-1 mice
29. Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: Implications for Parkinson's disease and memory
30. Estrogen modulates responses of striatal dopamine neurons to MPP(+): Evaluations using in vitro and in vivo techniques
31. A functional polymorphism in the monoamine oxidase A gene promoter
32. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder
33. Mao-A and COMT polymorphisms and gene effects in narcolepsy